Picture of Organigram Holdings logo

OGI Organigram Holdings Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Annual income statement for Organigram Holdings, fiscal year end - September 30th, CAD millions except per share, conversion factor applied.

2019
August 31st
2020
August 31st
2021
August 31st
2022
August 31st
2023
September 30th
Period Length:12 M12 M12 M12 M13 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue80.486.879.2146162
Cost of Revenue
Gross Profit37.9-12.1-24.4-8.43-31
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses75.9227169188424
Operating Profit4.54-141-89.7-42.7-263
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-5.88-147-131-14.4-252
Provision for Income Taxes
Net Income After Taxes-9.5-136-131-14.3-249
Net Income Before Extraordinary Items
Extraordinary Items
Net Income-9.54-136-131-14.3-249
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-9.54-136-131-14.3-249
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.436-1.96-1.81-0.434-1.93
Dividends per Share